245 related articles for article (PubMed ID: 31243985)
1. Industrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis.
Vilas-Boas V; Gijbels E; Cooreman A; Van Campenhout R; Gustafson E; Leroy K; Vinken M
Chem Res Toxicol; 2019 Jul; 32(7):1327-1334. PubMed ID: 31243985
[TBL] [Abstract][Full Text] [Related]
2. Testing in vitro tools for the prediction of cholestatic liver injury induced by non-pharmaceutical chemicals.
Gijbels E; Devisscher L; Vinken M
Food Chem Toxicol; 2021 Jun; 152():112165. PubMed ID: 33819548
[TBL] [Abstract][Full Text] [Related]
3. Network-based Assessment on Chemical-induced Cholestatic Liver Injury.
Chen Q; Zheng J; Shao Y; Ai N; Wu L; Liu Y; Lu X; Fan X
Curr Top Med Chem; 2016; 16(30):3668-3677. PubMed ID: 27334198
[TBL] [Abstract][Full Text] [Related]
4. The role of invariant natural killer T cells in experimental xenobiotic-induced cholestatic hepatotoxicity.
Nong C; Zou M; Xue R; Bai L; Liu L; Jiang Z; Sun L; Huang X; Zhang L; Wang X
Biomed Pharmacother; 2020 Feb; 122():109579. PubMed ID: 31794947
[TBL] [Abstract][Full Text] [Related]
5. Rat precision-cut liver slices predict drug-induced cholestatic injury.
Starokozhko V; Greupink R; van de Broek P; Soliman N; Ghimire S; de Graaf IAM; Groothuis GMM
Arch Toxicol; 2017 Oct; 91(10):3403-3413. PubMed ID: 28391356
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms and in vitro models of drug-induced cholestasis.
Gijbels E; Vilas-Boas V; Deferm N; Devisscher L; Jaeschke H; Annaert P; Vinken M
Arch Toxicol; 2019 May; 93(5):1169-1186. PubMed ID: 30972450
[TBL] [Abstract][Full Text] [Related]
7. Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition.
Vilas-Boas V; Gijbels E; Jonckheer J; De Waele E; Vinken M
Environ Int; 2020 Mar; 136():105422. PubMed ID: 31884416
[TBL] [Abstract][Full Text] [Related]
8. Cholestasis induced by model organic anions protects from acetaminophen hepatotoxicity in male CD-1 mice.
Silva VM; Hennig GE; Manautou JE
Toxicol Lett; 2006 Jan; 160(3):204-11. PubMed ID: 16140478
[TBL] [Abstract][Full Text] [Related]
9. Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development.
Donato MT; López-Riera M; Castell JV; Gómez-Lechón MJ; Jover R
Toxicol Lett; 2016 Nov; 263():58-67. PubMed ID: 27765674
[TBL] [Abstract][Full Text] [Related]
10. Risperidone-induced cholestatic hepatitis.
Krebs S; Dormann H; Muth-Selbach U; Hahn EG; Brune K; Schneider HT
Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):67-9. PubMed ID: 11204814
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced cholestasis.
Bhamidimarri KR; Schiff E
Clin Liver Dis; 2013 Nov; 17(4):519-31, vii. PubMed ID: 24099015
[TBL] [Abstract][Full Text] [Related]
12. Cholestasis as a liver protective factor in paracetamol acute overdose.
Acevedo C; Bengochea L; Tchercansky DM; Ouviña G; Perazzo JC; Lago N; Lemberg A; Rubio MC
Gen Pharmacol; 1995 Nov; 26(7):1619-24. PubMed ID: 8690256
[TBL] [Abstract][Full Text] [Related]
13. Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals.
Vilas-Boas V; Gijbels E; Leroy K; Pieters A; Baze A; Parmentier C; Vinken M
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681664
[TBL] [Abstract][Full Text] [Related]
14. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
[TBL] [Abstract][Full Text] [Related]
15. Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis.
Van den Hof WFPM; Coonen MLJ; van Herwijnen M; Brauers K; Jennen D; Olde Damink SWM; Schaap FG; Kleinjans JCS
Toxicol In Vitro; 2017 Oct; 44():322-329. PubMed ID: 28778767
[TBL] [Abstract][Full Text] [Related]
16. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced cholestasis.
Bjornsson ES; Jonasson JG
Clin Liver Dis; 2013 May; 17(2):191-209. PubMed ID: 23540497
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of hepatotoxicity and cholestasis in rats treated with EtOH extract of Fructus Psoraleae.
Wang J; Jiang Z; Ji J; Li Y; Chen M; Wang Y; Zhang Y; Tai T; Wang T; Zhang L
J Ethnopharmacol; 2012 Oct; 144(1):73-81. PubMed ID: 22954498
[TBL] [Abstract][Full Text] [Related]
19. Dataset on transcriptomic profiling of cholestatic liver injury induced by food additives and a cosmetic ingredient.
Gijbels E; Devisscher L; Vinken M
Data Brief; 2021 Oct; 38():107373. PubMed ID: 34589561
[TBL] [Abstract][Full Text] [Related]
20. Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent.
Parmentier C; Hendriks DFG; Heyd B; Bachellier P; Ingelman-Sundberg M; Richert L
Toxicol Lett; 2018 Oct; 295():187-194. PubMed ID: 29913214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
